Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
- PMID: 17136093
- DOI: 10.1038/nature05268
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Similar articles
-
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.Nature. 2006 Nov 30;444(7119):638-42. doi: 10.1038/nature05327. Nature. 2006. PMID: 17136094
-
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22. Nat Cell Biol. 2007. PMID: 17450133
-
Oncogene-induced senescence as an initial barrier in lymphoma development.Nature. 2005 Aug 4;436(7051):660-5. doi: 10.1038/nature03841. Nature. 2005. PMID: 16079837
-
Oncogene-induced senescence: putting the brakes on tumor development.Cancer Res. 2006 Mar 15;66(6):2881-4. doi: 10.1158/0008-5472.CAN-05-4006. Cancer Res. 2006. PMID: 16540631 Review.
-
Tipping the balance: Cdk2 enables Myc to suppress senescence.Cancer Res. 2010 Sep 1;70(17):6687-91. doi: 10.1158/0008-5472.CAN-10-1383. Epub 2010 Aug 16. Cancer Res. 2010. PMID: 20713526 Review.
Cited by
-
Cyclooxygenase-2 induces neoplastic transformation by inhibiting p53-dependent oncogene-induced senescence.Sci Rep. 2021 May 10;11(1):9853. doi: 10.1038/s41598-021-89220-5. Sci Rep. 2021. PMID: 33972599 Free PMC article.
-
Changing the History of Prostate Cancer with New Targeted Therapies.Biomedicines. 2021 Apr 6;9(4):392. doi: 10.3390/biomedicines9040392. Biomedicines. 2021. PMID: 33917592 Free PMC article. Review.
-
Leveraging the replication stress response to optimize cancer therapy.Nat Rev Cancer. 2023 Jan;23(1):6-24. doi: 10.1038/s41568-022-00518-6. Epub 2022 Nov 2. Nat Rev Cancer. 2023. PMID: 36323800 Free PMC article. Review.
-
Error-promoting DNA synthesis in ovarian cancer cells.Gynecol Oncol. 2013 Oct;131(1):198-206. doi: 10.1016/j.ygyno.2013.06.022. Epub 2013 Jul 12. Gynecol Oncol. 2013. PMID: 23851291 Free PMC article.
-
Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases.Int Rev Neurobiol. 2020;155:203-234. doi: 10.1016/bs.irn.2020.03.019. Epub 2020 Aug 11. Int Rev Neurobiol. 2020. PMID: 32854855 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
